title: 5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.
authors.affiliation: Medical Oncology Unit, Hospital Germans Trias i Pujol, Badalona, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Abad
authors.forename: R
authors.initials: R
authors.lastname: Rosell
authors.forename: A
authors.initials: A
authors.lastname: Barnadas
authors.forename: J
authors.initials: J
authors.lastname: Carles
authors.forename: N
authors.initials: N
authors.lastname: Ribelles
authors.forename: V
authors.initials: V
authors.lastname: Solano
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001661:Biliary Tract Neoplasms / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate
chemical_list: D008937:Mitomycins; D016685:Mitomycin; D005472:Fluorouracil; D007069:Ifosfamide